Ubiquitin E3 ligase MARCH10 targets influenza hemagglutinin for ubiquitination
- PMID: 40749991
- PMCID: PMC12376759
- DOI: 10.1016/j.cellsig.2025.112035
Ubiquitin E3 ligase MARCH10 targets influenza hemagglutinin for ubiquitination
Abstract
Influenza virus infection damages the airways and can cause acute lung injury. Influenza virus infection remains difficult to combat since treatment is limited to supportive care or antiviral drugs to prevent influenza early in the condition. Influenza hemagglutinin (HA) is the surface glycoprotein that facilitates viral entry by binding to sialic acid-containing receptors on the host's lung cells. Therefore, it is a promising target for the development of anti-influenza therapeutic drugs. We demonstrate that the understudied E3 ligase MARCH10 destabilizes influenza HA protein in a dose-response manner and decreases the half-life of influenza HA over time. However, it does not affect the mRNA expression of influenza HA. Further, MARCH10 specifically polyubiquitinates influenza HA targeting it for degradation. When BEAS-2B cells ectopically expressed MARCH10 and were infected with PR8 virus, 1378 genes were differentially expressed. In addition, our analysis reveals that MARCH10 upregulates multiple pathways that involved interferon signaling during influenza virus infection. These findings suggest that MARCH10 plays a protective role during influenza virus infection and may enhance airway host defense and innate immunity.
Keywords: E3 ubiquitin ligase; Hemagglutinin; Influenza; Interferon signaling; MARCH10; Ubiquitination.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Influenza virus reduces ubiquitin E3 ligase MARCH10 expression to decrease ciliary beat frequency.Am J Physiol Lung Cell Mol Physiol. 2023 May 1;324(5):L666-L676. doi: 10.1152/ajplung.00191.2022. Epub 2023 Feb 28. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 36852930 Free PMC article.
-
Equine lentivirus Gag protein degrades mitochondrial antiviral signaling protein via the E3 ubiquitin ligase Smurf1.J Virol. 2025 Jan 31;99(1):e0169124. doi: 10.1128/jvi.01691-24. Epub 2024 Dec 12. J Virol. 2025. PMID: 39665545 Free PMC article.
-
Comparative IP-MS Reveals HSPA5 and HSPA8 Interacting with Hemagglutinin Protein to Promote the Replication of Influenza A Virus.Pathogens. 2025 May 27;14(6):535. doi: 10.3390/pathogens14060535. Pathogens. 2025. PMID: 40559543 Free PMC article.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- Putri W, Muscatello DJ, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960–6. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical